Shopping Cart
- Remove All
- Your shopping cart is currently empty
Tenofovir (GS 1278) is an adenine analog REVERSE TRANSC-RIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $37 | In Stock | |
10 mg | $50 | In Stock | |
25 mg | $71 | In Stock | |
50 mg | $95 | In Stock | |
100 mg | $133 | In Stock | |
500 mg | $336 | In Stock | |
1 mL x 10 mM (in DMSO) | $46 | In Stock |
Description | Tenofovir (GS 1278) is an adenine analog REVERSE TRANSC-RIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone. |
In vitro | 4 μM Tenofovir completely inhibited the growth of HIVIIIB in MT-2 cells.Tenofovir inhibited hepatitis B virus (HBV) activity in HepG2 2.2.15, HepAD38 and HepAD79 cells. Tenofovir reduced the viral cytopathic effects of HIV-1(IIIB), HIV-2(ROD) and HIV(EHO) in MT-4 cells with EC50s of 1.15 μg/mL, 1.12 μg/mL, and 1.05 μg/mL.Tenofovir also reduced the viral cytopathic effects of SIV(mac251), SIV(B670), SHIV(89.6) and SHIV(89.6). Tenofovir also reduced the cytopathic effect of SIV(mac251),SIV(B670),SHIV(89.6) and SHIV(RTSHIV).Tenofovir showed unique activity against polynucleoside-resistant HIV expressing the Q151M mutation, and was less susceptible to viruses with the T69S insertion mutation. |
In vivo | 4 μM Tenofovir completely inhibited the growth of HIVIIIB in MT-2 cells.Tenofovir inhibited hepatitis B virus (HBV) activity in HepG2 2.2.15, HepAD38 and HepAD79 cells. Tenofovir reduced the viral cytopathic effects of HIV-1(IIIB), HIV-2(ROD) and HIV(EHO) in MT-4 cells with EC50s of 1.15 μg/mL, 1.12 μg/mL, and 1.05 μg/mL.Tenofovir also reduced the viral cytopathic effects of SIV(mac251), SIV(B670), SHIV(89.6) and SHIV(89.6). Tenofovir also reduced the cytopathic effect of SIV(mac251),SIV(B670),SHIV(89.6) and SHIV(RTSHIV).Tenofovir showed unique activity against polynucleoside-resistant HIV expressing the Q151M mutation, and was less susceptible to viruses with the T69S insertion mutation. |
Cell Research | Cells are plated into 48-well tissue culture plates (39,000 cells/mL) and allowed to grow for 48 h followed by treatment with vehicle or Tenofovir. Following the treatment period, cell viability is assessed using the MTT assay. The MTT assay relies on the conversion of tetrazolium dye 3-(4,5-dimethlthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to formazan by NAD(P)H-dependent oxidoreductases[1]. |
Alias | TDF, PMPA, GS 1278 |
Molecular Weight | 287.21 |
Formula | C9H14N5O4P |
Cas No. | 147127-20-6 |
Smiles | C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(O)(O)=O |
Relative Density. | 1.79 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 4 mg/mL (13.92 mM), Heating is recommended. Ethanol: < 1 mg/mL (insoluble or slightly soluble) H2O: 2 mg/mL (6.96 mM) | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
H2O/DMSO
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.